Adaptimmune Therapeutics PLC Annual Depreciation in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Adaptimmune Therapeutics PLC quarterly/annual Depreciation history and growth rate from 2013 to 2023.
  • Adaptimmune Therapeutics PLC Depreciation for the quarter ending March 31, 2024 was $2.77M, a 67% increase year-over-year.
  • Adaptimmune Therapeutics PLC annual Depreciation for 2023 was $9.45M, a 79.5% increase from 2022.
  • Adaptimmune Therapeutics PLC annual Depreciation for 2022 was $5.27M, a 6.47% decline from 2021.
  • Adaptimmune Therapeutics PLC annual Depreciation for 2021 was $5.63M, a 15% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $9.45M +$4.19M +79.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-06
2022 $5.27M -$364K -6.47% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 $5.63M -$997K -15% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-06
2020 $6.63M -$545K -7.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-06
2019 $7.17M -$16K -0.22% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-14
2018 $7.19M +$2.16M +42.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $5.03M +$1.91M +61% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-27
2016 $3.13M +$2.42M +343% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $705K +$465K +194% Jul 1, 2014 Jun 30, 2015 10-K 2018-03-15
2014 $240K +$193K +411% Jul 1, 2013 Jun 30, 2014 10-K 2017-03-13
2013 $47K Jul 1, 2012 Jun 30, 2013 8-K 2016-07-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.